Hypertrophic pulmonary osteoarthropathy associated with non-small cell lung cancer demonstrated growth hormone-releasing hormone by immunohistochemical analysis

27Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Hypertrophic pulmonary osteoarthropathy (HPO) associated with non-small cell lung cancer in a 58-year-old man was accompanied by an elevated serum level of growth hormone (GH). HPO rapidly disappeared after resection of the primary tumor and the elevation of serum GH was resolved. Immunohistochemically the tumor contained growth hormone-releasing hormone (GHRH) but not GH. These findings suggest that the high serum GH level due to ectopic GHRH production in the tumor, was a contributing factor in HPO. This is the second reported case of nonsmall cell lung cancer which was immunohistochemically positive for GHRH associated with HPO.

Cite

CITATION STYLE

APA

Mito, K., Maruyama, R., Uenishi, Y., Arita, K., Kawano, H., Kashima, K., & Nasu, M. (2001). Hypertrophic pulmonary osteoarthropathy associated with non-small cell lung cancer demonstrated growth hormone-releasing hormone by immunohistochemical analysis. Internal Medicine, 40(6), 532–535. https://doi.org/10.2169/internalmedicine.40.532

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free